A carregar...
Designing tuberculosis vaccine efficacy trials – lessons from recent studies
Introduction: Tuberculosis (TB) is the leading infectious killer globally and new TB vaccines will be crucial to ending the epidemic. Since the introduction in 1921 of the only currently licensed TB vaccine, BCG, very few novel vaccine candidates or strategies have advanced into clinical efficacy tr...
Na minha lista:
| Publicado no: | Expert Rev Vaccines |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492041/ https://ncbi.nlm.nih.gov/pubmed/30892969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2019.1593143 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|